Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B
Links shared publicly online about this topic.
- 675total visits
Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B
Investigators report no evidence of toxicity in the four hemophilia B patients enrolled to date in a gene therapy trial using a vector under development at St. Jude Children--™s Research Hospital and UCL (University College London) to correct the inherited bleeding disorder.
View full resource at newswise.com
Tags: Hemophilia, Poison, Healthcare, Hospital, Genes, Hospitals, Safety
Most Recently Shared on December 6, 2010 at 5:22 pm By:
Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B: Investigators rep... http://bit.ly/i9h1bw
Advertisement
